Trial Profile
A pilot study on the effect of ARA290 on pain and pain responses and retinal edema in patients with diabetes mellitus and neuropathic pain
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Apr 2013
Price :
$35
*
At a glance
- Drugs Cibinetide (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 15 Nov 2012 Primary endpoint 'Brief-Pain-Inventory' has not been met.
- 25 Jun 2011 New trial record